BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4251354)

  • 1. [Treatment of systemic scleroderma with high dosage of intravenous hyaluronidase].
    Petter O; Bellmann H
    Hautarzt; 1971 Jan; 22(1):32-3. PubMed ID: 4251354
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hyaluronidase therapy of progressive scleroderma].
    Mahrle G; Herrmann WP; Steigleder GK
    Hautarzt; 1972 Jul; 23(7):305-7. PubMed ID: 4655110
    [No Abstract]   [Full Text] [Related]  

  • 3. [Theoretical aspects of the new possibilities of use of hyaluronidase].
    Petter O; Bellmann H
    Z Gesamte Inn Med; 1971 Mar; 26(5):171-4. PubMed ID: 5560774
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyaluronidase Treatment of Scleroderma-Induced Microstomia.
    Melvin OG; Hunt KM; Jacobson ES
    JAMA Dermatol; 2019 Jul; 155(7):857-859. PubMed ID: 31141116
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic effectiveness of ultrasonics and lidase phonophoresis in various forms of scleroderma].
    Didenko IG
    Vestn Dermatol Venerol; 1978 Jun; (6):76-9. PubMed ID: 354249
    [No Abstract]   [Full Text] [Related]  

  • 6. [Our experience in the treatment of progressive scleroderma with hyaluronidase].
    Janković D; Mladenović P; Arnerić S; Stanković K
    Srp Arh Celok Lek; 1975 Jun; 103(6):531-4. PubMed ID: 1209350
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment with hyaluronidase in dermatology].
    Wozniak KD; Braun W
    Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1109-10. PubMed ID: 1226845
    [No Abstract]   [Full Text] [Related]  

  • 8. [Initial results of high-dosage hyaluromidase long-term therapy ("Hylase" Dessau) in dermatology].
    Wozniak KD; Braun W
    Dtsch Gesundheitsw; 1972 Jun; 27(22):1046-8. PubMed ID: 4557763
    [No Abstract]   [Full Text] [Related]  

  • 9. A neoteric multidrug combination: novel approach to limited cutaneous systemic scleroderma involving the face.
    Kumar MH; Kumar MS; Kumar SH; Kumar KS
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 27033280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of generalized (progressive) scleroderma].
    Balda BR
    Dtsch Med Wochenschr; 1972 Dec; 97(48):1876-8. PubMed ID: 4117979
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of systemic lupus erythematosus and systemic scleroderma with heparin].
    Gorbunova ZV; Iakimova NIa; Sukhanov AA; Grinberg NB
    Klin Med (Mosk); 1974; 52(8):55-8. PubMed ID: 4418071
    [No Abstract]   [Full Text] [Related]  

  • 12. Aberrant serum hyaluronan and hyaluronidase levels in scleroderma.
    Neudecker BA; Stern R; Connolly MK
    Br J Dermatol; 2004 Mar; 150(3):469-76. PubMed ID: 15030329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histomorphologic and histochemical changes in the skin during the treatment of scleroderma].
    Sych LI; Trofimova LIa
    Vestn Dermatol Venerol; 1971; 45(3):22-6. PubMed ID: 5122538
    [No Abstract]   [Full Text] [Related]  

  • 14. [The risk of intravenous treatment with hyaluronidase from a dermatological viewpoint].
    Richter G; Richter W
    Dermatol Monatsschr; 1975 Nov; 161(11):952-5. PubMed ID: 1204907
    [No Abstract]   [Full Text] [Related]  

  • 15. Small intestinal scleroderma with malabsorption and pneumatosis cystoides intestinalis. Report of three cases.
    Meihoff WE; Hirschfield JS; Kern F
    JAMA; 1968 Jun; 204(10):854-8. PubMed ID: 5694734
    [No Abstract]   [Full Text] [Related]  

  • 16. Unique chest roentgenogram in scleroderma.
    Zuckner J; Martin J
    Am J Roentgenol Radium Ther Nucl Med; 1971 Mar; 111(3):605-6. PubMed ID: 5548760
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of scleroderma with depolymerizing agents].
    Konopík J; Krs V
    Cas Lek Cesk; 1982 Nov; 121(44):1368-72. PubMed ID: 7172189
    [No Abstract]   [Full Text] [Related]  

  • 18. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects.
    Shapiro LS; Prince RK; Buckingham RB; Rodnan GP
    J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [On the modification of serum and urinary mucopolysaccharides of patients with scleroderma using gestagen therapy].
    Holzmann H; Korting GW; Morsches B
    Arch Klin Exp Dermatol; 1968; 231(2):156-60. PubMed ID: 4233426
    [No Abstract]   [Full Text] [Related]  

  • 20. [Scleroderma and polyarthritits].
    Lemaitre G; L'Hermine C
    J Radiol Electrol Med Nucl; 1968 May; 49(5):376-7. PubMed ID: 5678479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.